Skip to main content
Clinical Trials/NCT04361773
NCT04361773
Unknown
Phase 1

Effect of Photobiomodulation on the Treatment of Soft Tissue Traumatic Injuries: Study Protocol for a Double-Blind, Randomized, Controlled Trial

University of Nove de Julho0 sites84 target enrollmentMay 30, 2020

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Soft Tissue Injuries
Sponsor
University of Nove de Julho
Enrollment
84
Primary Endpoint
Change of the wound healing process using the BATES-JENSEN scale
Last Updated
6 years ago

Overview

Brief Summary

Soft tissue injuries are directly related to the energy of the trauma and its repair is the main factor for bone healing and the recovery of the function of the affected limb. Photobiomodulation (PBM) is indicated as an adjuvant treatment to accelerate wound healing, however, there is still a lack of evidence regarding its effect on traumatic soft tissue injuries. This project aims to evaluate the effects of the application of PBM in the resolution of complex soft tissue injuries of traumatic origin associated with tibial fractures. 84 adult individuals, aged between 18 and 60 years, hospitalized with tibial fractures awaiting resolution of soft tissue injuries will be included to undergo definitive surgery. The subjects will be randomized in two groups: PBM (treated with a device with 144 LED emitting diodes at wavelengths of 420, 660 and 850nm, 3J per point for 10 minutes) and Sham (simulation of the LED application, with a device with characteristics identical to that of the PBM group, for the same period of time). Subjects will be treated daily until release for surgery. The primary outcome will be the assessment of the wound healing process using the BATES-JENSEN scale. Secondary outcomes will be: pain intensity; consumption of analgesic drugs; serum evolution of inflammatory markers C-reactive protein and creatine kinase, measurement of the lesion area, time needed for release for definitive surgery, presence of infection, and the cost-effectiveness of PBM. The evaluations will be carried out before the beginning of the intervention and daily until the participant is considered ready for surgery (which will be considered the end of the experimental period). Data will be analyzed statistically considering a significance level of 5%.

Registry
clinicaltrials.gov
Start Date
May 30, 2020
End Date
December 30, 2021
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sandra Kalil Bussadori

Principal Investigator

University of Nove de Julho

Eligibility Criteria

Inclusion Criteria

  • Adult individuals of both sexes, aged between 18 and 60 years;
  • Interned in the Orthopedics and Infirmary Emergency Room of the Surgical Clinic of Conjunto Hospitalar do Mandaqui;
  • Victims of high-energy trauma in the lower limbs with sufficient soft tissue injury to make primary closure unfeasible or definitive treatment of injuries in the initial care associated with tibial fracture.

Exclusion Criteria

  • Diagnosis of chronic systemic diseases (renal failure, diabetes mellitus, hypertension, peripheral vascular insufficiency);
  • Allergy to cefazolin and gentamicin;
  • Uncontrollable active bleeding;
  • Occlusive arteriopathies;
  • Compartmental syndrome;
  • Necrosis in the area of neurovascular injury with sensory deficit at the injury site;
  • History of previous surgeries on the affected limb;
  • Local or systemic changes that contraindicate surgical intervention or hinder the postoperative period;
  • Photo sensitivity history;
  • Neurological and psychiatric disorders;

Outcomes

Primary Outcomes

Change of the wound healing process using the BATES-JENSEN scale

Time Frame: Baseline and through study completion, an average of 1 month.

Evaluation of the healing process of soft tissue injuries in lower limbs associated with tibial fractures caused by high-energy trauma using the variation in the Bates Jensen Wound Assessment Tool scale score. The current version of BWAT contains 13 items that measure size, depth, borders, detachment, type and amount of necrotic tissue, type and amount of exudate, edema and hardening of the peripheral tissue, skin color around the wound, granulation tissue and epithelialization. The measurement scale is of the Likert type, with five points, where 1 indicates the best condition of the wound and 5, the worst condition. The total score is obtained with the sum of all items and can vary from 13 to 65 points, with the highest scores indicating the worst wound conditions. The items size, depth, edges and detachment should be scored as zero when the lesions are healed. The instrument contains two additional items - location and shape - that are not part of the total score.

Secondary Outcomes

  • Change in Pain Intensity Through VAS(Baseline and through study completion, an average of 1 month.)
  • Consumption of painkillers(Baseline and through study completion, an average of 1 month.)
  • Change in serum evolution of inflammatory markers(Baseline, every three days and through study completion, an average of 1 month.)
  • Change in Lesion Area Measurement(Baseline and through study completion, an average of 1 month.)
  • Time needed for liberation for definitive surgery(Baseline and through study completion, an average of 1 month.)
  • Cost effectiveness of Photobiomodulation(Baseline and through study completion, an average of 1 month.)
  • Presence of Infection(Baseline and through study completion, an average of 1 month.)
  • Change in Peripheral Perfusion through Clinical Evaluation(Baseline and through study completion, an average of 1 month.)

Similar Trials